Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Philogen SpA ( (IT:PHIL) ) has shared an announcement.
Philogen has continued its share buyback programme on Euronext Milan, repurchasing 6,729 shares between 6 and 10 April 2026, equal to 0.0166% of its share capital, for a total outlay of about €136,600 at an average price of roughly €20.30 per share. Since the programme’s launch the company has acquired 65,610 shares for around €1.43 million, bringing total treasury holdings to 359,560 shares, or 0.8854% of share capital, a modest consolidation of ownership that may support capital management flexibility and signal confidence to investors.
The group, which specialises in targeted oncology drugs based on high-affinity ligands and vascular targeting strategies, continues to invest in its platform aimed at treating conditions with limited therapeutic options. Its sustained buyback activity occurs against this backdrop of long-term R&D investment, underscoring management’s effort to balance shareholder-focused measures with the pursuit of innovative cancer and inflammatory disease therapies.
The most recent analyst rating on (IT:PHIL) stock is a Hold with a EUR18.00 price target. To see the full list of analyst forecasts on Philogen SpA stock, see the IT:PHIL Stock Forecast page.
More about Philogen SpA
Philogen is an Italian-Swiss biotechnology group focused on discovering and developing targeted anti-cancer drugs for diseases with high mortality rates. Leveraging proprietary antibody and small-molecule ligand technologies, it pursues tumor and vascular targeting approaches to deliver potent agents directly to tumor tissue while sparing healthy cells, and it is building a portfolio of innovative therapies and related intellectual property that may extend to certain chronic inflammatory diseases.
YTD Price Performance: -14.25%
Average Trading Volume: 19,718
Technical Sentiment Signal: Hold
Current Market Cap: €584.3M
See more insights into PHIL stock on TipRanks’ Stock Analysis page.